- About Us
- Career Center
- Nano-Social Network
- Nano Consulting
- My Account
The Institute of Nanotechnology, global leader in nanotechnology information services, is organising its second annual nanomedicine conference and exhibition which will showcase the latest developments in medical nanotechnologies and potential routes to finance. The two day event will see leading multinational companies, such as Philips, AstraZeneca, GE Healthcare, GlaxoSmithKline, Volcano Corporation and Fresenius Medical Care, sharing their vision of the impacts of nanomedicine on healthcare and providing a window on their activities.
Key discussions will be on the changing practice of healthcare, challenges in integrating nanomedicine into established business models, managing ‘risks and uncertainties' , the role of public-private partnerships in building value, requirements for better regulation and standardisation as well as the barriers to the clinic. The conference will also have three main technology sessions, 'Drug Delivery and Pharmaceutical Development', ‘Tissue Engineering and Regenerative Medicine' and 'Novel Devices, Nanosensors, Diagnostics and Imaging'.
The Head of ‘Nanosciences and Nanotechnologies' unit at The European Commission will outline the EC's nanomedicine plan and how some of the €800million dedicated under FP7 will be targeted towards new nanotechnology-based treatments. The Wellcome Trust will present details about their funding priorities and new technology transfer initiatives and EMEA will summarise their views on regulatory hurdles. The conference will also see a number of innovative small companies' presenting novel nanomedical technologies and presentations from top scientists as far away as India and Malaysia. The associated exhibition will showcase new innovations in nanomedicine and provide a unique opportunity to network with potential partners.
Investing in Medical Nanotechnology II builds upon the success of the inaugural event held last year to bring the latest developments in the exciting and dynamic new field of nanomedicine. The event sponsored by Marks & Clerk, MTI Partners and Tinytech Jobs will take place on 28-29 November at the historic and prestigious Royal College of Surgeons in London. Further details are available at http://nanomednet.org/conference07/ or alternatively contact Tiju Joseph at the Institute of Nanotechnology on +44 (0) 141 330 8734.
For more information, please click here
+44 (0) 141 330 8734
Copyright © Institute of NanotechnologyIf you have a comment, please Contact us.
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
|Related News Press|
Nanobiotix Provides Update on Global Development of Lead Product NBTXR3: Seven clinical trials across the world: More than 2/3 of STS patients recruited in the “act.in.sarc” Phase II/III trial: Phase I/II prostate cancer trial now recruiting in the U.S. November 28th, 2016
Nanopolymer-modified protein array can pinpoint hard-to-find cancer biomarker November 17th, 2016
Nanotechnology Treatment Found to Inhibit Mesothelioma Tumor Growth November 16th, 2016
Quantum obstacle course changes material from superconductor to insulator December 1st, 2016
Throwing new light on printed organic solar cells December 1st, 2016
IEDM: Leti CEO Marie Semeria to Give Opening-day Keynote on Impact of ‘Hyperconnectivity’ and IoT: Speech to Portray Key Role Nonprofit Research and Technology Organizations Play in Making Technology More Efficient and Ensuring Safety and Security November 29th, 2016
Cutting-edge nanotechnologies are breaking into industries November 18th, 2016